Work

Safety, tolerability, and immunogenicity of WGc-043 in subjects with EBV-positive cancers: Results from an investigator-initiated trial.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.23_suppl.139

Authors: Xingchen Peng, Xuan He, Weiwei Zhang, Hai Huang, Xue Li, Jie Chen, Yuquan Wei, Xiangrong Song

Institutions: Sichuan University, West China Hospital of Sichuan University, West China Medical Center of Sichuan University, State Key Laboratory of Biotherapy

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401514575

Cites:

Cited by: 9

Related to: 10